Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 169

1.

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

Quasar Collaborative Group, Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ.

Lancet. 2007 Dec 15;370(9604):2020-9.

PMID:
18083404
[PubMed - indexed for MEDLINE]
2.
4.

Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.

Focan C, Bury J, Beauduin M, Herman ML, Vindevoghel A, Lecomte M, Brohée D, Canon JL, Focan-Henrard D; GRECCR Belgium.

Anticancer Res. 2000 Nov-Dec;20(6C):4665-72.

PMID:
11205198
[PubMed - indexed for MEDLINE]
5.

Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.

Scheithauer W, Kornek GV, Marczell A, Karner J, Salem G, Greiner R, Burger D, Stöger F, Ritschel J, Kovats E, Vischer HM, Schneeweiss B, Depisch D.

Br J Cancer. 1998 Apr;77(8):1349-54.

PMID:
9579845
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study.

Punt CJ, Nagy A, Douillard JY, Figer A, Skovsgaard T, Monson J, Barone C, Fountzilas G, Riess H, Moylan E, Jones D, Dethling J, Colman J, Coward L, MacGregor S.

Lancet. 2002 Aug 31;360(9334):671-7.

PMID:
12241873
[PubMed - indexed for MEDLINE]
8.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
[PubMed - indexed for MEDLINE]
9.

Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.

Porschen R, Bermann A, Löffler T, Haack G, Rettig K, Anger Y, Strohmeyer G; Arbeitsgemeinschaft Gastrointestinale Onkologie.

J Clin Oncol. 2001 Mar 15;19(6):1787-94.

PMID:
11251010
[PubMed - indexed for MEDLINE]
Free Article
10.

Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.

Kerr DJ, McArdle CS, Ledermann J, Taylor I, Sherlock DJ, Schlag PM, Buckels J, Mayer D, Cain D, Stephens RJ; Medical Research Council's colorectal cancer study group; European Organisation for Research and Treatment of Cancer colorectal cancer study group.

Lancet. 2003 Feb 1;361(9355):368-73.

PMID:
12573372
[PubMed - indexed for MEDLINE]
11.
12.

Comparison of the levogyre and dextro-levogyre forms of leucovorin in a phase III trial of bimonthly LV5FU2 versus monthly 5-fluorouracil and high-dose leucovorin for patients with stage II and III colon cancer (GERCOR C96.1).

Baumgaertner I, Quinaux E, Khalil A, Louvet C, Buyse M, de Gramont A, André T; GERCOR Group.

Clin Colorectal Cancer. 2010 Apr;9(2):E5-10. doi: 10.3816/CCC.2010.n.027.

PMID:
20378497
[PubMed - indexed for MEDLINE]
13.

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.

O'Connell MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ, Wieand HS.

J Clin Oncol. 1997 Jan;15(1):246-50.

PMID:
8996149
[PubMed - indexed for MEDLINE]
Free Article
14.

Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinoma.

Scheithauer W, Kornek G, Rosen H, Sebesta C, Marcell A, Kwasny W, Karall M, Depisch D.

Eur J Cancer. 1995 Nov;31A(12):1981-6.

PMID:
8562152
[PubMed - indexed for MEDLINE]
15.

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

Haller DG, Catalano PJ, Macdonald JS, O'Rourke MA, Frontiera MS, Jackson DV, Mayer RJ.

J Clin Oncol. 2005 Dec 1;23(34):8671-8.

PMID:
16314627
[PubMed - indexed for MEDLINE]
Free Article
16.

A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.

Kelsen DP, Saltz L, Cohen AM, Yao TJ, Enker W, Tong W, Tao Y, Bertino JR.

Cancer. 1994 Oct 15;74(8):2224-33.

PMID:
7922973
[PubMed - indexed for MEDLINE]
17.

Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion.

Arkenau HT, Rettig K, Porschen R.

Int J Colorectal Dis. 2005 May;20(3):258-61. Epub 2004 Nov 11.

PMID:
15549327
[PubMed - indexed for MEDLINE]
18.

The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial.

Mosconi S, Cascinu S, Zaniboni A, Catalano V, Giordani P, Beretta GD, Martignoni G, Pancera G, Baldelli AM, Poletti P, Curti C, Labianca R.

Tumori. 2000 Nov-Dec;86(6):465-9.

PMID:
11218187
[PubMed - indexed for MEDLINE]
19.

Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.

Jäger E, Heike M, Bernhard H, Klein O, Bernhard G, Lautz D, Michaelis J, Meyer zum Büschenfelde KH, Knuth A.

J Clin Oncol. 1996 Aug;14(8):2274-9.

PMID:
8708717
[PubMed - indexed for MEDLINE]
Free Article
20.

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial.

Wood C, Srivastava P, Bukowski R, Lacombe L, Gorelov AI, Gorelov S, Mulders P, Zielinski H, Hoos A, Teofilovici F, Isakov L, Flanigan R, Figlin R, Gupta R, Escudier B; C-100-12 RCC Study Group.

Lancet. 2008 Jul 12;372(9633):145-54. doi: 10.1016/S0140-6736(08)60697-2. Epub 2008 Jul 3.

PMID:
18602688
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk